MARZILLI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 21.048
AS - Asia 9.821
EU - Europa 6.427
SA - Sud America 1.036
AF - Africa 344
Continente sconosciuto - Info sul continente non disponibili 265
OC - Oceania 20
Totale 38.961
Nazione #
US - Stati Uniti d'America 20.439
SG - Singapore 3.064
CN - Cina 3.021
IT - Italia 1.863
HK - Hong Kong 1.574
SE - Svezia 1.028
BR - Brasile 890
VN - Vietnam 685
BG - Bulgaria 683
DE - Germania 538
CA - Canada 509
KR - Corea 508
UA - Ucraina 497
TR - Turchia 416
FI - Finlandia 391
GB - Regno Unito 356
RU - Federazione Russa 323
FR - Francia 317
CH - Svizzera 208
JP - Giappone 115
IN - India 112
NG - Nigeria 108
CI - Costa d'Avorio 97
BD - Bangladesh 68
IQ - Iraq 60
AR - Argentina 45
ZA - Sudafrica 36
NL - Olanda 32
BE - Belgio 31
PK - Pakistan 31
MX - Messico 30
ES - Italia 27
VE - Venezuela 25
MA - Marocco 20
PL - Polonia 19
SN - Senegal 19
UZ - Uzbekistan 19
CO - Colombia 18
EC - Ecuador 18
SA - Arabia Saudita 17
AT - Austria 16
ID - Indonesia 15
JM - Giamaica 15
CL - Cile 13
IR - Iran 13
PH - Filippine 13
AZ - Azerbaigian 12
EG - Egitto 12
CZ - Repubblica Ceca 11
DZ - Algeria 11
JO - Giordania 11
KE - Kenya 11
AU - Australia 10
BJ - Benin 10
IE - Irlanda 10
NZ - Nuova Zelanda 10
HN - Honduras 9
PY - Paraguay 9
TT - Trinidad e Tobago 9
CR - Costa Rica 8
GR - Grecia 8
PE - Perù 8
HU - Ungheria 7
IL - Israele 7
LT - Lituania 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
PR - Porto Rico 6
TN - Tunisia 6
BB - Barbados 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EE - Estonia 5
HR - Croazia 5
KZ - Kazakistan 5
LB - Libano 5
TH - Thailandia 5
AL - Albania 4
BO - Bolivia 4
ET - Etiopia 4
KG - Kirghizistan 4
MK - Macedonia 4
NP - Nepal 4
RS - Serbia 4
SV - El Salvador 4
UY - Uruguay 4
BH - Bahrain 3
BY - Bielorussia 3
EU - Europa 3
GE - Georgia 3
IS - Islanda 3
LU - Lussemburgo 3
PT - Portogallo 3
TW - Taiwan 3
BM - Bermuda 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CY - Cipro 2
GY - Guiana 2
Totale 38.663
Città #
Woodbridge 2.556
Ann Arbor 1.845
Ashburn 1.805
Singapore 1.732
Houston 1.665
Hong Kong 1.560
Fairfield 1.461
Chandler 1.156
San Jose 882
Dallas 724
Milan 723
Hefei 703
Seattle 698
Sofia 682
Jacksonville 680
Santa Clara 673
Beijing 516
Cambridge 511
Seoul 500
Wilmington 496
Shanghai 489
New York 467
Ottawa 421
Council Bluffs 398
Princeton 305
Boardman 289
Izmir 266
Lawrence 264
Medford 252
Nanjing 240
Los Angeles 239
Lauterbourg 230
Bern 204
Des Moines 182
Dearborn 160
Serra 150
Ho Chi Minh City 135
Buffalo 130
Istanbul 128
Jüchen 125
Dong Ket 121
Lagos 106
Tokyo 102
Abidjan 97
Nanchang 93
Hanoi 91
Redondo Beach 71
London 70
Florence 66
San Diego 65
Frankfurt am Main 63
São Paulo 63
Helsinki 59
Redwood City 56
Rome 53
Kunming 51
Shenyang 51
Munich 48
Boulder 47
Tianjin 40
Hebei 38
Norwalk 37
Ogden 37
Changsha 35
Düsseldorf 34
Brooklyn 31
Brussels 28
Falls Church 27
Orem 26
Rio de Janeiro 26
Chicago 25
Guangzhou 25
Jiaxing 25
Phoenix 24
Montreal 23
The Dalles 23
Pune 22
Columbus 21
Da Nang 21
Haiphong 21
Baghdad 20
Fuzhou 20
Johannesburg 20
Dakar 19
Pisa 19
Belo Horizonte 18
Brasília 18
Tashkent 18
Toronto 18
Dhaka 17
Detroit 16
Hangzhou 16
San Francisco 16
Verona 16
Biên Hòa 15
Lancaster 15
Orange 15
Atlanta 14
Nuremberg 14
Turku 14
Totale 28.942
Nome #
Effects of dilazep on coronary and systemic hemodynamics in humans 234
Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link! 223
Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update 221
Assessment of Coronary Flow Reserve by Transesophageal Doppler: Different Response to Adenosine or Dipyridamole 219
Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 218
New Echocardiographic Techniques in the Evaluation of Left Ventricular Mechanics in Subclinical Thyroid Dysfunction 216
Systolic and diastolic alterations of left ventricular function: prevalence in ischaemic heart disease and importance in the management of individual patients 215
Coronary vasospasm in angina pectoris 213
Intramyocardial pressure and coronary extravascular resistance 213
Different respiratory activities of mitochondria isolated from the subendocardium and subepicardium of the canine heart 212
Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease 212
Efficacy Comparison of Trimetazidine with Therapeutic Alternatives in Stable Angina Pectoris: A Network Meta-Analysis. 212
Right ventricular remodelling in systemic hypertension: a cardiac MRI study 211
2D Strain in the evaluation of early alteration of global and regional left ventricular function in pre-hypertension 209
Advantages of real time three-dimensional echocardiography in the assessment of right ventricular volumes and function in patients with pulmonary hypertension compared with conventional two-dimensional echocardiography. 208
Relative role of coronary stenosis severity and morphology in determining pharmacologic stress echo positivity 206
Possibilities, limitations, and technique for the study of regional myocardial perfusion in man by Xenon-133 205
Regional myocardial perfusion in patients with atherosclerotic coronary artery disease, at rest and during angina pectoris induced by tachycardia 204
"Ischemia at a distance" during intermittent coronary artery occlusion: a coronary anatomic explanation 202
In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans 202
A Multiparametric Clinical and Echocardiographic Score to Risk Stratify Patients with Chronic Systolic Heart Failure: Derivation and Testing 202
Trimetazidine 201
The relative role of subendocardium and subepicardium in left ventricular mechanics 200
Gli score clinici nell’insufficienza cardiaca cronica: esiste uno score ideale 199
Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography 199
A new technique for multitracer macroscopic autoradiography 198
Regional and global biventricular function during dipyridamole stress testing 198
New echocardiographic techniques in the evaluation of left ventricular function in obesity 197
Assessment of papillary muscle function in the intact heart 196
Modulating effect of regional myocardial performance on local myocardial perfusion in the dog 195
Coronary vasodilation by nitrates is not mediated by the prostaglandin system: an angiographic and hemodynamic study 195
Determination of biomarkers in oral fluid for monitoring heart failure patients 195
Pharmacological approaches to coronary microvascular dysfunction 194
Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium 192
Interaction between coronary artery stenosis and coronary microcirculation in ischemic heart disease 192
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 192
Prognostic value of cardiac power output to left ventricular mass in patients with left ventricular dysfunction and dobutamine stress echo negative by wall motion criteria 192
Dipyridamole-echocardiography test in patients with exercise-induced ST-segment elevation 191
Determination of volatile organic compounds in human breath for monitoring heart failure patients 190
Relation of intramyocardial pressure to coronary pressure at zero flow 189
Does trimetazidine prevent myocardial injury after percutaneous coronary intervention? 189
Significance of spasm in the pathogenesis of ischemic heart disease 187
Assessment of coronary reserve by transoesophageal Doppler echocardiography. Direct comparison between different modalities of dipyridamole and adenosine administration 187
Intracardiac echocardiography in patients with pacing and defibrillating leads: a feasibility study 187
Resting heart rate is an independent predictor of left ventricular diastolic dysfunction in obese patients with or without arterial hypertension 187
Stress Testing After Complete and Successful Coronary Revascularization 187
Coronary occlusion: cause or consequence of acute myocardial infarction? 185
Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4 185
Changing scenario in chronic ischemic heart disease: therapeutic implications 185
Usefulness of high-dose dipyridamole echocardiography test in coronary angioplasty 183
Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing 183
Interactions Between Reciprocal ST-Segment Downsloping During ST-Elevated Myocardial Infarction and Global Cardiac Perfusion and Functional Abnormalities 183
Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention 182
Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up 181
Advantages of real time three-dimensional echocardiography in the assessment of right ventricular volumes and function in patients with pulmonary hypertension compared with conventional two-dimensional echocardiography. 181
Transient myocardial dysfunction during pharmacologic vasodilation as an index of reduced coronary reserve: a coronary hemodynamic and echocardiographic study 180
Efficacy of perindopril in reduction cardiovascular events among patients with stable coronary artery disease:randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) 179
Effect of dilazep on coronary and systemic circulations 178
Immunologic detection of endothelial cells in human whole blood 178
Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage 178
Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertension 177
Persistence of subendocardial perfusion after subtotal coronary embolisation 176
Coronary vasodilation by nitrates is not mediated by the prostaglandin system: a quantitative cineangiographic study 176
Complex coronary artery lesion morphology influences results of stress echocardiography 176
Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials 176
Studies of regional myocardial perfusion in the anginal patient 175
Adenosine-induced renal vasoconstriction in man 175
Prognostic Value of Pulsed Tissue Doppler Imaging for the Assessment of Left Ventricular Systolic Function in Patients with Nonischemic Dilated Cardiomyopathy 175
The potential value of integrated natriuretic peptide and echo-guided heart failure management 175
Quantitative assessment of coronary atherosclerotic plaque profile by morphometric analysis of angiographic images 174
Right-sided heart failure in carcinoid syndrome 174
Prognostic value of echo-derived peak cardiac power output-to-left ventricular mass compared to cardiopulmonary exercise testing in patients with chronic stable systolic heart failure 174
The 'Echo Heart Failure Score': An echocardiographic risk prediction score of mortality in systolic heart failure 173
Myocardial protection during PCI in STEMI : strategy reperfusion effects in acute MI patients (stream study) 172
Predicting Heart Failure Patient Events by Exploiting Saliva and Breath Biomarkers Information 172
Microvascular dysfunction in collateral-dependent myocardium 171
Prognostic Value of Pulsed Tissue Doppler Imaging for the Assessment of Left Ventricular Systolic Function in Patients with Nonischemic Dilated Cardiomyopathy 171
Impact of real time 3D-echocardiography in the assessment of right ventricular volumes and function in patients with pulmonary hypertension 171
Estimation of Heart Failure Patients Medication Adherence through the Utilization of Saliva and Breath Biomarkers and Data Mining Techniques 171
From the experimental myocardial infarction to the clinical acute myocardial infarction: limitations of thrombolytic therapy 170
Coronary vasodilation by nitrates: any role for prostaglandins? 169
Increased pressor responsiveness to exercise and reduced exercise tolerance are associated with abnormal myocardial perfusion in patients with essential hypertension and normal coronary angiograms 169
Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy 169
Nonuniformity of the transmural distribution of coronary blood flow during the cardiac cycle. In vivo documentation by contrast echocardiography 168
2D-Strain in the evaluation of early alterations of global and regional left ventricular function in pre-hypertension 168
Peak Power Output to Left Ventricular Mass: An Index to Predict Ventricular Pumping Performance and Morbidity in Advanced Heart Failure 168
A computational approach for the estimation of heart failure patients status using saliva biomarkers 168
"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients 167
Patterns of left ventricular remodeling in chronic heart failure: Prevalence and prognostic implications 167
Coronary effects of adenosine in conscious man 166
Selective vasodilatation of the subepicardial coronary vasculature induced by carbochromen (author's transl) 165
Coronary extravascular compression influences systolic coronary blood flow 165
Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina 165
Trimetazidine and Other Metabolic Modifiers 165
DETERMINATION OF BIOMARKERS IN BREATH AND SALIVA FOR MONITORING HEART FAILURE PATIENTS 164
The second law of thermodynamics and the heart 164
About EMIP-FR and reperfusion damage in AMI: a comment to the comment 163
Global alteration in perfusion response to increasing oxygen consumption in patients with single-vessel coronary artery disease 162
Impact of chronic patency of infarct-related coronary artery on prevalence of myocardial ischemia during the pharmacologic and exercise stress test 162
Appropriateness of use criteria in echocardiography: an Italian experience 162
Totale 18.617
Categoria #
all - tutte 102.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.619 0 130 41 188 548 366 65 117 168 54 123 819
2022/20233.102 429 341 170 250 473 435 18 234 480 21 214 37
2023/20242.594 510 322 362 153 377 409 47 77 47 33 45 212
2024/20257.156 19 299 68 413 453 598 508 398 813 1.074 937 1.576
2025/20267.535 545 1.203 986 546 708 779 1.169 328 337 585 221 128
2026/2027699 144 555 0 0 0 0 0 0 0 0 0 0
Totale 38.961